iinews – Der mobile Newsdienst



« | »

New report examines the Biosimilars Market worth USD 23.63 Billion by 2023

 

The report \“Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing Type (In-house, Contract), Disease (Oncology, Autoimmune) – Global Forecast to 2023\“, [181 Pages Report] The biosimilars market is expected to reach USD 23.63 Billion by 2023 from USD 5.95 Billion in 2018, at a CAGR of 31.7%.

Various key industry players of the generics market have started working on the manufacturing and clinical trial activities of MAbs. At present, approximately 50 biosimilar MAbs are in the pipeline. Bioexpress Therapeutic (Switzerland) has 16 biosimilar candidates of MAbs that are in the pipeline. The other players that have invested in the production of MAbs are GeneTechno Science (Japan), Celltrion (South Korea), Zydus-Cadila (India), Biocon (India), and Samsung Biologics (South Korea).

Download PDF Sample Pages of Varicose Vein Treatment Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40

The objectives of this study are as follows:

To define, describe, segment, and forecast the biosimilars market by product, type of manufacturing, disease, and region
To forecast the size of the market with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To track and analyze competitive developments such as collaborations, regulatory approvals, partnerships, acquisitions, and product launches in the biosimilars market
Get Sample Report with all Graphs & Charts related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=40

Scope of the Report:

This report categorizes the biosimilars market into the following segments:

Biosimilars Market, By Product
Recombinant Non-glycosylated Proteins
Recombinant Human Growth Hormone
Interferons
Recombinant Glycosylated Proteins
Erythropoietin
Monoclonal Antibodies
Recombinant Peptides
Glucagon
Biosimilars Market, By Type of Manufacturing
In-house Manufacturing
Biosimilars Market, By Disease
Oncology
Blood Disorders
Infectious Diseases
Biosimilars Market, By Region
North America
Europe
Asia
Rest of the World
To speak to our analyst for a discussion on the above findings, click @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=40

Posted by on 22. April 2019.

Tags: , , , , , , , , ,

Categories: Bilder, Vermischtes

0 Responses

You must be logged in to post a comment.

« | »




Neue Beiträge


Seiten